CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	CxApp	Common Stock	Common Stock CxApp	Common Stock Public Offering	Additional Paid-In Capital	Additional Paid-In Capital CxApp	Additional Paid-In Capital Public Offering	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Non-Controlling Interest	Series 7 Preferred Stock	Series 7 Preferred Stock Additional Paid-In Capital	Series 8 Preferred Stock	Series 8 Preferred Stock Additional Paid-In Capital	Series 4 Convertible Preferred Stock	Series 4 Convertible Preferred Stock Convertible Preferred Stock	Series 5 Convertible Preferred Stock	Series 5 Convertible Preferred Stock Convertible Preferred Stock
Increase (Decrease) in Temporary Equity [Roll Forward]
Convertible preferred stock, beginning balance (in shares)													49,250		0
Convertible preferred stock, beginning balance													$ 44,695		$ 0
Series 7 Preferred redeemed for cash (in shares)													(49,250)
Series 7 Preferred redeemed for cash													$ (49,250)
Series 8 Preferred stock issued for cash (in shares)															53,197.72
Series 8 Preferred stock issued for cash															$ 41,577
Accretion discount - preferred shares													$ 4,555		548
Deemed dividend for the modification related to Series 8 Preferred Stock															2,627
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock															(1,469)
Amortization Premium- modification related to Series 8 Preferred Stock															$ (110)
Convertible preferred stock, ending balance (in shares) at Mar. 31, 2022													0		53,198
Convertible preferred stock, ending balance at Mar. 31, 2022													$ 0		$ 43,173
Balance, beginning (in shares) at Dec. 31, 2021																		1		126
Balance, beginning at Dec. 31, 2021	$ 83,491		$ 2			$ 332,761			$ (695)	$ 44	$ (250,309)	$ 1,688						$ 0		$ 0
Balance, beginning (in shares) at Dec. 31, 2021			1,730,140
Balance, beginning (in shares) at Dec. 31, 2021									(1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued for net cash proceeds of a public offering (in shares)			57,472
Common shares issued for net cash proceeds of a public offering	1,500					1,500									5,329	$ 5,329
Stock options and restricted stock awards granted to employees for services	1,533					1,533
Accretion discount - preferred shares													$ (4,555)	$ (4,555)	(548)	(548)
Deemed dividend for the modification related to Series 8 Preferred Stock															(2,627)	(2,627)
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock															1,469	1,469
Amortization Premium- modification related to Series 8 Preferred Stock															$ 110	110
Restricted stock grants withheld for taxes (in shares)			(12,802)
Restricted stock grants withheld for taxes	(336)					(336)
Common shares issued for CXApp earnout (in shares)				144,986
Common shares issued for CXApp earnout		$ 3,697					$ 3,697
Common shares issued for exchange of warrants (in shares)			184,153
Cumulative translation adjustment	(102)									(102)	(15)	15
Net income (loss)	(11,557)										(11,211)	(346)
Balance, ending (in shares) at Mar. 31, 2022																		1		126
Balance, ending (in shares) at Mar. 31, 2022			2,103,949
Balance, ending at Mar. 31, 2022	77,404		$ 2			338,333			$ (695)	(58)	(261,535)	1,357						$ 0		$ 0
Balance, ending (in shares) at Mar. 31, 2022									(1)
Convertible preferred stock, ending balance (in shares) at Sep. 30, 2022													53,198
Convertible preferred stock, ending balance at Sep. 30, 2022													$ 53,198
Balance, beginning (in shares) at Dec. 31, 2021																		1		126
Balance, beginning at Dec. 31, 2021	83,491		$ 2			332,761			$ (695)	44	(250,309)	1,688						$ 0		$ 0
Balance, beginning (in shares) at Dec. 31, 2021			1,730,140
Balance, beginning (in shares) at Dec. 31, 2021									(1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(49,880)
Balance, ending (in shares) at Sep. 30, 2022																		1		126
Balance, ending (in shares) at Sep. 30, 2022			2,250,596
Balance, ending at Sep. 30, 2022	33,790		$ 2			331,487			$ (695)	1,496	(299,123)	622						$ 0		$ 0
Balance, ending (in shares) at Sep. 30, 2022									(1)
Increase (Decrease) in Temporary Equity [Roll Forward]
Convertible preferred stock, beginning balance (in shares)													0		53,198
Convertible preferred stock, beginning balance													$ 0		$ 43,173
Accretion discount - preferred shares															6,236
Amortization Premium- modification related to Series 8 Preferred Stock															$ (1,251)
Convertible preferred stock, ending balance (in shares) at Jun. 30, 2022													0		53,198
Convertible preferred stock, ending balance at Jun. 30, 2022													$ 0		$ 48,158
Balance, beginning (in shares) at Mar. 31, 2022																		1		126
Balance, beginning at Mar. 31, 2022	77,404		$ 2			338,333			$ (695)	(58)	(261,535)	1,357						$ 0		$ 0
Balance, beginning (in shares) at Mar. 31, 2022			2,103,949
Balance, beginning (in shares) at Mar. 31, 2022									(1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options and restricted stock awards granted to employees for services	741					741
Common shares issued for cashless stock options exercised (in shares)			35,062
Common shares issued for cashless stock options exercised	500					500
Accretion discount - preferred shares															$ (6,236)	(6,236)
Restricted stock grants withheld for taxes	1,251
Cumulative translation adjustment	657									656	(56)	57
Net income (loss)	(20,330)										(19,872)	(458)
Balance, ending (in shares) at Jun. 30, 2022																		1		126
Balance, ending (in shares) at Jun. 30, 2022			2,139,011
Balance, ending at Jun. 30, 2022	53,987		$ 2			334,589			$ (695)	598	(281,463)	956						$ 0		$ 0
Balance, ending (in shares) at Jun. 30, 2022									(1)
Increase (Decrease) in Temporary Equity [Roll Forward]
Convertible preferred stock, beginning balance (in shares)													0		53,198
Convertible preferred stock, beginning balance													$ 0		$ 48,158
Series 8 Preferred stock issued for cash													$ 6,305
Convertible preferred stock, ending balance (in shares) at Sep. 30, 2022													53,198
Convertible preferred stock, ending balance at Sep. 30, 2022													$ 53,198
Increase (Decrease) in Temporary Equity [Roll Forward]
Preferred Stock converted to common stock													$ (1,265)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued for extinguishment of debt (in shares)			111,585
Common shares issued for extinguishment of debt	1,250					1,250
Stock options and restricted stock awards granted to employees for services	688					688
Accretion discount - preferred shares	(6,305)					(6,305)
Amortization Premium- modification related to Series 8 Preferred Stock															$ 1,265	$ 1,265
Cumulative translation adjustment	897									898	(69)	68
Net income (loss)	(17,993)										(17,591)	(402)
Balance, ending (in shares) at Sep. 30, 2022																		1		126
Balance, ending (in shares) at Sep. 30, 2022			2,250,596
Balance, ending at Sep. 30, 2022	33,790		$ 2			331,487			$ (695)	1,496	(299,123)	622						$ 0		$ 0
Balance, ending (in shares) at Sep. 30, 2022									(1)
Increase (Decrease) in Temporary Equity [Roll Forward]
Convertible preferred stock, beginning balance (in shares)													53,198
Convertible preferred stock, beginning balance													$ 53,198
Balance, beginning (in shares) at Dec. 31, 2022																	1	1	126	126
Balance, beginning at Dec. 31, 2022	$ 32,115		$ 4			346,668			$ (695)	1,061	(313,739)	(1,184)						$ 0		$ 0
Balance, beginning (in shares) at Dec. 31, 2022	3,570,893		3,570,894
Balance, beginning (in shares) at Dec. 31, 2022	(1)								(1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued for extinguishment of debt (in shares)	1,547,234		1,547,234
Common shares issued for extinguishment of debt	$ 1,426		$ 1			1,425
Common shares issued for net cash proceeds of a public offering (in shares)					9,655,207
Common shares issued for net cash proceeds of a public offering	14,966				$ 10			$ 14,956
Stock options and restricted stock awards granted to employees for services	329					329
Deconsolidation of CXApp business as result of spin off		$ (24,230)					$ (24,230)
Common shares issued for net proceeds from warrants exercised (in shares)			1,380,000
Common shares issued for net proceeds from warrants exercised	1		$ 1
Common shares issued for exchange of warrants (in shares)			324,918
Cumulative translation adjustment	(1,250)									(1,259)	26	(17)
Net income (loss)	(17,178)										(16,873)	(305)
Balance, ending (in shares) at Mar. 31, 2023																		1		126
Balance, ending (in shares) at Mar. 31, 2023			16,478,253
Balance, ending at Mar. 31, 2023	6,179		$ 16			339,148			$ (695)	(198)	(330,586)	(1,506)						$ 0		$ 0
Balance, ending (in shares) at Mar. 31, 2023									(1)
Convertible preferred stock, ending balance (in shares) at Sep. 30, 2023													0
Balance, beginning (in shares) at Dec. 31, 2022																	1	1	126	126
Balance, beginning at Dec. 31, 2022	$ 32,115		$ 4			346,668			$ (695)	1,061	(313,739)	(1,184)						$ 0		$ 0
Balance, beginning (in shares) at Dec. 31, 2022	3,570,893		3,570,894
Balance, beginning (in shares) at Dec. 31, 2022	(1)								(1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued for cashless stock options exercised (in shares)	0
Net income (loss)	$ (35,355)
Balance, ending (in shares) at Sep. 30, 2023															0		1	1	126	126
Balance, ending (in shares) at Sep. 30, 2023	111,692,177		111,692,178
Balance, ending at Sep. 30, 2023	$ 7,882		$ 112			358,692			$ (695)	41	(347,971)	(2,297)						$ 0		$ 0
Balance, ending (in shares) at Sep. 30, 2023	(1)								(1)
Balance, beginning (in shares) at Mar. 31, 2023																		1		126
Balance, beginning at Mar. 31, 2023	$ 6,179		$ 16			339,148			$ (695)	(198)	(330,586)	(1,506)						$ 0		$ 0
Balance, beginning (in shares) at Mar. 31, 2023			16,478,253
Balance, beginning (in shares) at Mar. 31, 2023									(1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued for extinguishment of debt (in shares)			7,349,420
Common shares issued for extinguishment of debt	2,020		$ 7			2,013
Common shares issued for net cash proceeds of a public offering (in shares)					19,326,522
Common shares issued for net cash proceeds of a public offering	5,417				$ 20			5,397
Stock options and restricted stock awards granted to employees for services	241					241
Cumulative translation adjustment	9									9	(3)	3
Net income (loss)	(7,329)										(6,966)	(363)
Balance, ending (in shares) at Jun. 30, 2023																		1		126
Balance, ending (in shares) at Jun. 30, 2023			43,154,195
Balance, ending at Jun. 30, 2023	$ 6,537		$ 43			346,799			$ (695)	(189)	(337,555)	(1,866)						$ 0		$ 0
Balance, ending (in shares) at Jun. 30, 2023									(1)
Convertible preferred stock, ending balance (in shares) at Sep. 30, 2023													0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued for extinguishment of debt (in shares)	18,144,158		18,144,158
Common shares issued for extinguishment of debt	$ 3,178		$ 18			3,160
Common shares issued for exercise of warrants (in shares)			9,000,000
Common shares issued for exercise of warrants	2,430		$ 9			2,421
Common shares issued for net cash proceeds of a public offering (in shares)					41,393,825
Common shares issued for net cash proceeds of a public offering	6,127				$ 42			$ 6,085
Stock options and restricted stock awards granted to employees for services	227					227
Cumulative translation adjustment	231									230	(32)	33
Net income (loss)	$ (10,848)										(10,384)	(464)
Balance, ending (in shares) at Sep. 30, 2023															0		1	1	126	126
Balance, ending (in shares) at Sep. 30, 2023	111,692,177		111,692,178
Balance, ending at Sep. 30, 2023	$ 7,882		$ 112			$ 358,692			$ (695)	$ 41	$ (347,971)	$ (2,297)						$ 0		$ 0
Balance, ending (in shares) at Sep. 30, 2023	(1)								(1)
Increase (Decrease) in Temporary Equity [Roll Forward]
Convertible preferred stock, beginning balance (in shares)													0